We followed this by mechanistic work in vitro that resulted in the identification of junctional adhesion molecule A (JAM-A) as a novel important target gene dysregulated by EZH2 in lupus T cells (3).
The mean number of JAMA benchmarks (maximum four) present for the 'systemic lupus erythematosus', 'SLE' and 'lupus' searches was 1.3 (SD 1.2), 1.4 (SD 1.3) and 1.2 (SD 1.0), respectively, with no statistically significance difference.